by GlobeNewsWire | Sep 7, 2016 | Canadian Stocks, Globe Newswire
BURNABY, British Columbia, Sept. 07, 2016 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, today announced that it has commenced an underwritten public offering of its common shares pursuant to its existing...
by GlobeNewsWire | Sep 7, 2016 | Globe Newswire
SOUTH SAN FRANCISCO, Calif., Sept. 07, 2016 (GLOBE NEWSWIRE) — Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that it has filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation to effect a 1-for-6 reverse stock...
by GlobeNewsWire | Sep 7, 2016 | Globe Newswire
PALO ALTO, Calif., Sept. 07, 2016 (GLOBE NEWSWIRE) — Cloudera, the global provider of the fastest, easiest, and most secure data management and analytics platform built on Apache Hadoop and the latest open source technologies, today announced it ranked #5 on the...
by GlobeNewsWire | Sep 7, 2016 | Globe Newswire
NEW YORK, Sept. 07, 2016 (GLOBE NEWSWIRE) — Extreme Reach is named to the first-ever Forbes 2016 Cloud 100, the definitive list of the top 100 private cloud companies in the world, developed in partnership with Bessemer Venture Partners. To view the list, please...
by GlobeNewsWire | Sep 7, 2016 | Globe Newswire
SAN FRANCISCO and CAMBRIDGE, United Kingdom, Sept. 07, 2016 (GLOBE NEWSWIRE) — Cantabio Pharmaceuticals, Inc. (OTCQB:CTBO) today announced the completion of a licensing agreement with Cambridge Enterprise that gives the company access to intellectual property...